Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China · Delayed Price · Currency is CNY 27.13
+1.19 (4.59%)
At close: Feb 13, 2026
SHA:688319 Market Cap
SHA:688319 has a market cap or net worth of 11.01 billion as of February 13, 2026. Its market cap has increased by 132.15% in one year.
Market Cap
11.01B
Enterprise Value
11.19B
Revenue
709.13M
Ranking
n/a
PE Ratio
170.92
Stock Price
27.13
Market Cap Chart
Since June 8, 2021, SHA:688319's market cap has decreased from 16.17B to 11.01B, a decrease of -31.93%. That is a compound annual growth rate of -7.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 11.01B | 6.92% |
| Dec 31, 2025 | 10.29B | 139.25% |
| Dec 31, 2024 | 4.30B | -32.95% |
| Dec 29, 2023 | 6.42B | 14.17% |
| Dec 30, 2022 | 5.62B | -61.27% |
| Dec 31, 2021 | 14.51B | -10.25% |
| Jun 8, 2021 | 16.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 11.35B |
| Aurisco Pharmaceutical | 10.95B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.94B |
| Liaoning Chengda Biotechnology | 10.65B |
| Chongqing Genrix Biopharmaceutical | 10.53B |
| Chengzhi | 10.45B |
| Bio-Thera Solutions | 10.04B |
| Youcare Pharmaceutical Group | 9.69B |